NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,157 | +53.6% | 56,099 | +57.6% | 0.00% | 0.0% |
| Q2 2023 | $264,508 | -2.9% | 35,600 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $272,391 | -93.0% | 39,306 | -81.7% | 0.00% | -94.4% |
| Q3 2022 | $3,908,000 | -16.7% | 214,722 | +135.4% | 0.02% | -10.0% |
| Q2 2022 | $4,691,000 | +1112.1% | 91,220 | +1639.2% | 0.02% | +1900.0% |
| Q1 2022 | $387,000 | -95.1% | 5,245 | -90.6% | 0.00% | -96.2% |
| Q4 2021 | $7,946,000 | -11.0% | 55,543 | +28.9% | 0.03% | -16.1% |
| Q3 2021 | $8,929,000 | +1541.4% | 43,074 | +1338.7% | 0.03% | +1450.0% |
| Q1 2021 | $544,000 | -65.6% | 2,994 | -78.9% | 0.00% | -71.4% |
| Q4 2020 | $1,583,000 | +65.8% | 14,197 | +60.9% | 0.01% | +75.0% |
| Q3 2020 | $955,000 | -91.1% | 8,823 | -93.2% | 0.00% | -92.6% |
| Q2 2020 | $10,767,000 | – | 129,184 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |